Publication | Open Access

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule

VaccinationVaccine DevelopmentImmunologyVirologyVaccine DesignMedicineVaccine ResearchRecombinant CanarypoxvirusB7.1 Co-stimulatory Molecule